Skip to main content
SpringerLink
Log in

Maternal Use of Drugs for Intestinal Problems, Except Intestinal Inflammations, and Infant Congenital Malformations

  • Chapter
  • First Online:
Maternal Drug Use and Infant Congenital Malformations

Abstract

Rather low but statistically significant malformation risk increases were seen after maternal use of drugs for functional intestinal diseases and for anti-propulsive drugs. These effects may be explained by a confounding by indication, perhaps as a result of nutritional disturbances.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Czeizel AE, Kazy Z, Puhó E. A population-based case-control teratological study of oral nystatin treatment during pregnancy. Scand J Infect Dis. 2003;35:830–5.

    Article  CAS  Google Scholar 

  • Heinonen OP, Slone D, Shapiro S. Birth defects and drugs during pregnancy. Littttleton, MA: Publishing Sciences Group Inc.; 1977.

    Google Scholar 

  • Einarson A, Mastroiacovo P, Arnon J, Ornoy A, Addis A, Malm H, Koren G. Prospective, controlled, multicenter study of loperamide in pregnancy. Can J Gastroenterol. 2000;14:185–7.

    Article  CAS  Google Scholar 

  • Källén B. Congenital malformations in the offspring when drugs for functional gastrointestinal disease were used during early pregnancy. Intern Med. 2014;S1:004. https://doi.org/10.4172/2165-8048.S1-004.

    Article  Google Scholar 

  • Källén B, Nilsson E, Otterblad Olausson P. Maternal use of loperamide in early pregnancy and delivery outcome. Acta Paediatr. 2008;97:541–5.

    Article  Google Scholar 

  • Schwethelm B, Margulis LH, Miller C, Smith S. Risk status and pregnancy outcome among Medicaid recipients. Am J Prev Med. 1989;5:157–63.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tornblad Institute for Comparative Embryology, Lund University, Lund, Sweden

    Bengt Källén

Authors
  1. Bengt Källén
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Källén, B. (2019). Maternal Use of Drugs for Intestinal Problems, Except Intestinal Inflammations, and Infant Congenital Malformations. In: Maternal Drug Use and Infant Congenital Malformations. Springer, Cham. https://doi.org/10.1007/978-3-030-17898-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-17898-7_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-17897-0

  • Online ISBN: 978-3-030-17898-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation